These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9631566)

  • 1. Contact activation of blood coagulation: trigger properties and hysteresis. Kinetic recognition of foreign surfaces upon contact activation of blood coagulation: a hypothesis.
    Pokhilko AV; Ataullakhanov FI
    J Theor Biol; 1998 Mar; 191(2):213-9. PubMed ID: 9631566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contact factors in severe sepsis].
    Dosquet C; Wautier JL
    Presse Med; 1992 Feb; 21(5):210-5. PubMed ID: 1532087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revision of the biological significance of the contact system].
    Liu FY; He SL
    Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):7-12. PubMed ID: 12532760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated human platelets induce factor XIIa-mediated contact activation.
    Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
    Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasma kallikrein-kinin system: its evolution from contact activation.
    Schmaier AH; McCrae KR
    J Thromb Haemost; 2007 Dec; 5(12):2323-9. PubMed ID: 17883591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact system activation and high thrombin generation in hyperthyroidism.
    Kim N; Gu JY; Yoo HJ; Han SE; Kim YI; Nam-Goong IS; Kim ES; Kim HK
    Eur J Endocrinol; 2017 May; 176(5):583-589. PubMed ID: 28137735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inositol-phospholipid-accelerated activation of prekallikrein by activated factor XII at physiological ionic strength requires zinc ions and high-Mr kininogen.
    Schousboe I
    Eur J Biochem; 1990 Oct; 193(2):495-9. PubMed ID: 2226467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A renaissance for the contact system in blood coagulation?
    Blat Y; Seiffert D
    Thromb Haemost; 2008 Mar; 99(3):457-60. PubMed ID: 18327389
    [No Abstract]   [Full Text] [Related]  

  • 13. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.
    Park HS; Gu J; You HJ; Kim JE; Kim HK
    Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of HMW kininogen in surface-mediated activation of Factor XII.
    Shimada T; Sugo T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the contact phase of blood coagulation: effects of shear rate and surface are intertwined.
    Gregory K; Basmadjian D
    Ann Biomed Eng; 1994; 22(2):184-93. PubMed ID: 8074329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.